Published in Cancer on May 01, 2004
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer. J Clin Oncol (2009) 2.15
Photodynamic therapy for head and neck dysplasia and cancer. Arch Otolaryngol Head Neck Surg (2009) 1.30
Head and neck cancer: an evolving treatment paradigm. Cancer (2008) 1.21
Staging of laryngeal and hypopharyngeal cancer: value of imaging studies. Eur Radiol (2006) 1.02
Outcome after supracricoid laryngectomies in the material of ENT Department, Poznan University of Medical Sciences. Eur Arch Otorhinolaryngol (2011) 0.97
Survival after laryngectomy: a review of 133 patients with laryngeal carcinoma. Eur Arch Otorhinolaryngol (2009) 0.91
Definitive radiation therapy for early glottic cancer: experience of two fractionation schedules. Clin Exp Otorhinolaryngol (2012) 0.88
Laser surgery of early glottic cancer in elderly. Acta Otorhinolaryngol Ital (2010) 0.87
Glottic laser surgery: outcomes according to 2007 ELS classification. Eur Arch Otorhinolaryngol (2011) 0.87
Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer. Ann Oncol (2012) 0.85
Risk-adapted partial larynx and/or carotid artery sparing modulated radiation therapy of glottic cancer. Radiat Oncol (2014) 0.83
BCCIP as a prognostic marker for radiotherapy of laryngeal cancer. Radiother Oncol (2008) 0.81
Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy. Eur Arch Otorhinolaryngol (2013) 0.80
CO₂ laser cordectomy for T1-T2 glottic cancer: oncological and functional long-term results. Eur Arch Otorhinolaryngol (2015) 0.80
Definitive hypofractionated radiotherapy for early glottic carcinoma: experience of 55Gy in 20 fractions. Radiat Oncol (2015) 0.79
Volumetric modulated arc therapy for carotid sparing in the management of early glottic cancer. Radiat Oncol J (2016) 0.79
Long-term vocal functional results after glottectomy: a multi-dimensional analysis. Eur Arch Otorhinolaryngol (2007) 0.79
Estimation of daily interfractional larynx residual setup error after isocentric alignment for head and neck radiotherapy: quality assurance implications for target volume and organs-at-risk margination using daily CT on- rails imaging. J Appl Clin Med Phys (2014) 0.78
Impact of initial tumor volume on radiotherapy outcome in patients with T2 glottic cancer. Strahlenther Onkol (2014) 0.78
Quantitative analysis of myosin heavy chain expression change in laryngeal muscle after irradiation in rats. Yonsei Med J (2011) 0.78
Multicentric evaluation of strategies for treatment of T1a glottic carcinomas. Eur Arch Otorhinolaryngol (2014) 0.78
Transoral CO2 Laser Microsurgery Outcomes for Early Glottic Carcinomas T1-T2. Int Arch Otorhinolaryngol (2016) 0.77
Long-term survival rates of laryngeal cancer patients treated by radiation and surgery, radiation alone, and surgery alone: studied by lognormal and Kaplan-Meier survival methods. BMC Cancer (2005) 0.77
Transoral laser microsurgery versus radiotherapy for T1 glottic carcinoma: a systematic review and meta-analysis. Lasers Med Sci (2016) 0.77
Role of endolaryngeal surgery (with or without laser) compared with radiotherapy in the management of early (T1) glottic cancer: a clinical practice guideline. Curr Oncol (2013) 0.76
SBRT for early-stage glottic larynx cancer-Initial clinical outcomes from a phase I clinical trial. PLoS One (2017) 0.75
Current treatment of T1N0 squamous cell carcinoma of the glottic larynx. Eur Arch Otorhinolaryngol (2014) 0.75
The role of primary surgical treatment in young patients with squamous cell carcinoma of the larynx: a 20-year review of 34 cases. World J Surg Oncol (2015) 0.75
Efficacy Comparison Between Total Laryngectomy and Nonsurgical Organ-Preservation Modalities in Treatment of Advanced Stage Laryngeal Cancer: A Meta-Analysis. Medicine (Baltimore) (2016) 0.75
Transoral Laser Microsurgery in Early Glottic Lesions. Curr Otorhinolaryngol Rep (2017) 0.75
Guidelines for the Surgical Management of Laryngeal Cancer: Korean Society of Thyroid-Head and Neck Surgery. Clin Exp Otorhinolaryngol (2017) 0.75
Voice evaluation following endoscopic laser CO(2) cordectomy and conventional cordectomy. Arch Med Sci (2011) 0.75
Tumor Volumes and Prognosis in Laryngeal Cancer. Cancers (Basel) (2015) 0.75
Concurrent chemoradiotherapy with conventional fractionated radiotherapy and low-dose daily cisplatin plus weekly docetaxel for T2N0 glottic cancer. Radiat Oncol (2017) 0.75
Oncological and complication assessment of CO2 laser-assisted endoscopic surgery for T1-T2 glottic tumours: clinical experience. Acta Otorhinolaryngol Ital (2016) 0.75
T1-2 glottic cancer treated with radiotherapy and/or surgery. Strahlenther Onkol (2017) 0.75
Definitive radiation therapy for treatment of laryngeal carcinoma: impact of local relapse on outcome and implications for treatment strategies. Strahlenther Onkol (2013) 0.75
Adverse histopathological findings in glottic cancer with anterior commissure involvement. Eur Arch Otorhinolaryngol (2015) 0.75
Endolaryngeal cordectomy using cold instruments for treatment of T1 glottic cancers. Eur Arch Otorhinolaryngol (2007) 0.75
When is radiation therapy in head and neck squamous cell carcinoma not indicated? Eur Arch Otorhinolaryngol (2013) 0.75
Therapeutic modalities and oncologic outcomes in the treatment of T1b glottic squamous cell carcinoma: a systematic review. Eur Arch Otorhinolaryngol (2017) 0.75
When is definitive radiotherapy the preferred treatment for head and neck squamous cell carcinoma? Eur Arch Otorhinolaryngol (2015) 0.75
Management of surgical margins after endoscopic laser surgery for early glottic cancers: a multicentric evaluation in French-speaking European countries. Eur Arch Otorhinolaryngol (2015) 0.75
Radiotherapy for pleomorphic adenoma. Am J Otolaryngol (2012) 2.04
Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys (2007) 1.97
Ameloblastoma. Am J Clin Oncol (2007) 1.81
Squamous cell carcinoma of the oropharynx: surgery, radiation therapy, or both. Cancer (2002) 1.76
Cutaneous angiosarcoma. Am J Clin Oncol (2006) 1.60
Radiotherapy alone or combined with surgery for adenoid cystic carcinoma of the head and neck. Head Neck (2004) 1.59
Head and neck mucosal melanoma. Am J Clin Oncol (2005) 1.53
Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck (2002) 1.45
Linear accelerator surgery for meningiomas. J Neurosurg (2005) 1.43
Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol (2006) 1.42
Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site. Laryngoscope (2009) 1.33
T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapy. Int J Radiat Oncol Biol Phys (2010) 1.32
Postoperative irradiation for squamous cell carcinoma of the oral cavity: 35-year experience. Head Neck (2004) 1.30
Skull base chordoma. Head Neck (2005) 1.28
Salivary gland pleomorphic adenoma. Am J Clin Oncol (2008) 1.28
Postradiotherapy neck dissection for lymph node-positive head and neck cancer: the use of computed tomography to manage the neck. J Clin Oncol (2006) 1.27
Radiotherapy alone or combined with surgery for salivary gland carcinoma. Cancer (2005) 1.26
Head and neck paragangliomas. Head Neck (2010) 1.24
External beam radiotherapy for differentiated thyroid cancer. Am J Otolaryngol (2005) 1.21
Skin carcinoma of the head and neck with perineural invasion. Am J Otolaryngol (2011) 1.20
Mucosal melanoma of the head and neck. Am J Clin Oncol (2008) 1.19
Expressive disclosure and health outcomes in a prostate cancer population. Int J Psychiatry Med (2002) 1.17
Skin cancer of the head and neck with perineural invasion. Am J Clin Oncol (2007) 1.17
Adult head and neck soft tissue sarcomas. Head Neck (2005) 1.14
Carcinoma of the supraglottic larynx: treatment results with radiotherapy alone or with planned neck dissection. Head Neck (2002) 1.13
Radiation therapy for esthesioneuroblastoma: rationale for elective neck irradiation. Head Neck (2003) 1.13
Breast boost: are we missing the target? Cancer (2003) 1.12
Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope (2009) 1.12
Ewing tumors of the head and neck. Am J Clin Oncol (2010) 1.11
Cutaneous squamous cell carcinoma metastatic to parotid-area lymph nodes. Laryngoscope (2008) 1.09
Definitive radiotherapy for tonsillar squamous cell carcinoma. Am J Clin Oncol (2006) 1.07
Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neck. Head Neck (2003) 1.05
Adenoid cystic carcinoma of the head and neck. Am J Otolaryngol (2012) 1.04
Management of sinonasal undifferentiated carcinoma. Head Neck (2008) 1.04
A radiation oncologist's guide to contouring the hippocampus. Am J Clin Oncol (2009) 1.04
Intensity-modulated radiotherapy for oropharyngeal squamous cell carcinoma. Laryngoscope (2010) 1.02
Carcinoma of the skin with perineural invasion. Head Neck (2003) 1.02
Second tumors in pediatric patients treated with radiotherapy to the central nervous system. Am J Clin Oncol (2012) 1.01
Carotid-sparing intensity-modulated radiotherapy for early-stage squamous cell carcinoma of the true vocal cord. Int J Radiat Oncol Biol Phys (2009) 1.01
Definitive radiotherapy in the management of paragangliomas arising in the head and neck: a 35-year experience. Head Neck (2008) 1.01
Definitive radiotherapy for squamous cell carcinoma of the base of tongue. Am J Clin Oncol (2006) 1.00
Carcinoma of the skin of the head and neck with perineural invasion. Head Neck (2002) 1.00
Head and neck osteosarcoma. Am J Otolaryngol (2010) 0.99
Favorable outcomes of pediatric patients treated with radiotherapy to the central nervous system who develop radiation-induced meningiomas. Int J Radiat Oncol Biol Phys (2010) 0.98
Thyroid function should be monitored following radiotherapy to the low neck. Am J Clin Oncol (2005) 0.98
Smoking status and pain level among head and neck cancer patients. J Pain (2009) 0.98
Voice rehabilitation after total laryngectomy and postoperative radiation therapy. J Clin Oncol (2002) 0.97
Contouring the middle and inner ear on radiotherapy planning scans. Am J Clin Oncol (2005) 0.96
Adjuvant radiotherapy for cutaneous melanoma: comparing hypofractionation to conventional fractionation. Int J Radiat Oncol Biol Phys (2006) 0.96
Adult head and neck soft tissue sarcomas. Am J Clin Oncol (2005) 0.96
Radiotherapy and concomitant intraarterial cisplatin (RADPLAT) for advanced squamous cell carcinomas of the head and neck. Am J Clin Oncol (2007) 0.95
Tumor-volume simulation during radiotherapy for head-and-neck cancer using a four-level cell population model. Int J Radiat Oncol Biol Phys (2009) 0.95
Radiotherapy for carcinoma in situ of the true vocal cords. Head Neck (2002) 0.94
Impact of race on outcome after definitive radiotherapy for squamous cell carcinoma of the head and neck. Cancer (2003) 0.94
Stage IE primary non-Hodgkin's lymphoma of bone. Clin Orthop Relat Res (2002) 0.94
Results of the Association of Directors of Radiation Oncology Programs (ADROP) survey of radiation oncology residency program directors. Int J Radiat Oncol Biol Phys (2009) 0.93